ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!Kenvue Inc. (KVUE) stock declined over -0.24%, trading at $23.02 on NYSE, down from the previous close of $23.07. The stock opened at $23.10, fluctuating between $22.94 and $23.36 in the recent session.
Kenvue Inc. operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, and other products under the Tylenol, Nicorette, and Zyrtec brands. The Skin Health and Beauty segment provides face and body care, hair care, and sun and other care products under the Neutrogena, Aveeno, and OGX brand names. The Essential Health segment offers oral and baby, women's health, and wound care products under the Listerine, Johnson's, Band-Aid, and Stayfree brands. The company was incorporated in 2022 and is headquartered in Skillman, New Jersey. Kenvue Inc. operates as a subsidiary of Johnson & Johnson.
Employees | 22000 |
Beta | 1.21 |
Sales or Revenue | $15.44B |
5Y Sales Change% | 0.102% |
Fiscal Year Ends | December |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com